Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb The Motley Fool These two pharma stocks are beloved by income investors. Bristol Bristol-Myers Squibb (BMY) Dividend Investing NYSE Pfizer (PFE) Science Space 3 months
SPYD: Simple Dividend Equity ETF, Above-Average 4.0% Yield, Recent Outperformance Seeking Alpha 1 hour
Dividend Investor Making $110,000 Shares His Portfolio: Top 12 Stocks and ETFs You Might Be Missing Yahoo Finance 2 hours
Visa: Double-Digit Capital Appreciation And Dividend Growth Prospects – Reiterate Buy Seeking Alpha 2 hours
Is Hewlett Packard Enterprise Co (NYSE:HPE) the Best AI Stock to Buy After Earnings? Insider Monkey 3 hours
Analyst on Broadcom Inc (AVGO): Ignore ‘Minor Bump in the Road’ and Buy the Dip Insider Monkey 3 hours
British American Tobacco’s Shift to Smokeless: Progress Made, but Cigarette Declines Persist The Motley Fool 3 hours
This Nvidia ETF Has a Sky-High 77% Dividend Yield, but Should You Just Buy Nvidia Stock Instead? The Motley Fool 4 hours
3 Dividend Stocks to Buy Now That Have Raised Their Payouts for at Least 20 Consecutive Years The Motley Fool 5 hours
With huge NASA contract, Intuitive Machines closer to becoming ‘preeminent lunar infrastructure player’, says analyst MarketWatch 5 hours
The Zacks Analyst Blog Boot Barn Holdings, Abercrombie & Fitch, Sprouts Farmers Market and Burlington Stores Zacks 5 hours
These career break coaches help people quit their jobs to figure out their next step Fast Company 5 hours
C3.ai’s Chief Says It’s a “Mathematical Certainty” That the Company Will Be Profitable. But a Closer Look at the Numbers Says Something Else. The Motley Fool 5 hours
Novo Nordisk Just Took a $530 Million Step Onto Moderna’s Turf. Here’s What It Means for Both Stocks The Motley Fool 5 hours